PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points PHC has ...
T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...
GloboCare has received a Notice of Allowance from the China National Intellectual Property Administration for its patent ...
Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, announced today that it has received a Notice of Allowance ...
GlobalData on MSN10d
BMS’ Phase II trial of CAR T cell therapy meets primary endpointBristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback